Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2323
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients ; volume:46 ; number:4 ; day:12 ; month:1 ; year:2022 ; pages:813-819 ; date:4.2022
World journal of surgery ; 46, Heft 4 (12.1.2022), 813-819, 4.2022
- Creator
-
Alvarado, Luis
Sharma, Nishtha
Lerma, Roxann
Dwivedi, Alok
Ahmad, Adeel
Hechanova, Aimee
Payan-Schober, Fernanda
Nwosu, Azikiwe
Alkhalili, Eyas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00268-022-06439-7
- URN
-
urn:nbn:de:101:1-2022052823311782071787
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alvarado, Luis
- Sharma, Nishtha
- Lerma, Roxann
- Dwivedi, Alok
- Ahmad, Adeel
- Hechanova, Aimee
- Payan-Schober, Fernanda
- Nwosu, Azikiwe
- Alkhalili, Eyas
- SpringerLink (Online service)
Other Objects (12)
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease?
Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease?
Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease?